TURKISH JOURNAL OF UROLOGY, vol.46, no.1, pp.13-17, 2020 (ESCI)
Objective: To compare human menopausal gonadotropin (hMG) and recombinant follicle-stimulating hormone (rFSH) with respect to successful spermatogenesis and pregnancy outcomes in patients with congenital hypogonadotropic hypogonadism (CHH).